首页/数据集/KAT6B gene deletion as a predictive biomarker to Irinotecan response in small cell lung cancer

KAT6B gene deletion as a predictive biomarker to Irinotecan response in small cell lung cancer

NIAID Data Ecosystem2026-03-10 收录

小细胞肺癌药物基因组学

化疗反应生物标志物

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62775 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

应用场景：

创建时间：

2018-05-03

肉瘤基因组学

化疗反应生物标志物

Comprehensive literature reviews were also conducted to collect gene CNV amplification and deletion that can be predictive of clinical outcome in three types of sarcoma from the PubMed repository. (XL

Figshare2024-02-16 更新90

Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial

胰腺癌基因组学

化疗反应生物标志物

This study was aimed at investigating the genomic and transcriptomic features associated with response to the OXIRI regimen (oxaliplatin, irinotecan, capecitabine) in pancreatic ductal adenocarcinoma

NIAID Data Ecosystem50

Additional file 1 of Early changes in gene expression profiles in AML patients during induction chemotherapy

急性髓系白血病基因组学

化疗反应生物标志物

Additional file 1.

DataCite Commons2022-11-15 更新40

Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer

乳腺癌基因组预后预测

化疗反应生物标志物

PURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer. METHODS: We developed a microarray-bas

NIAID Data Ecosystem70

Additional file 2: of Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma

肉瘤基因组学

化疗反应生物标志物

Samples annotation for sarcoma patients and cell lines in the study. (XLSX 45 kb)

NIAID Data Ecosystem40